IRIS Accounts Production v24.3.0.553 11234753 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 14320 18373 86206 103692 80312 70999 20214 14320 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112347532023-03-31112347532024-03-31112347532023-04-012024-03-31112347532022-03-31112347532022-04-012023-03-31112347532023-03-3111234753ns15:EnglandWales2023-04-012024-03-3111234753ns14:PoundSterling2023-04-012024-03-3111234753ns10:Director12023-04-012024-03-3111234753ns10:Director22023-04-012024-03-3111234753ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111234753ns10:SmallEntities2023-04-012024-03-3111234753ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3111234753ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111234753ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111234753ns10:FullAccounts2023-04-012024-03-3111234753ns10:OrdinaryShareClass12023-04-012024-03-3111234753ns10:OrdinaryShareClass22023-04-012024-03-311123475342ns10:Director22023-03-311123475342ns10:Director22022-03-311123475342ns10:Director22023-04-012024-03-311123475342ns10:Director22022-04-012023-03-311123475342ns10:Director22024-03-311123475342ns10:Director22023-03-3111234753ns5:CurrentFinancialInstruments2024-03-3111234753ns5:CurrentFinancialInstruments2023-03-3111234753ns5:Non-currentFinancialInstruments2024-03-3111234753ns5:Non-currentFinancialInstruments2023-03-3111234753ns5:ShareCapital2024-03-3111234753ns5:ShareCapital2023-03-3111234753ns5:RetainedEarningsAccumulatedLosses2024-03-3111234753ns5:RetainedEarningsAccumulatedLosses2023-03-3111234753ns10:RegisteredOffice2023-04-012024-03-3111234753ns5:PlantMachinery2023-04-012024-03-3111234753ns5:PlantMachinery2023-03-3111234753ns5:PlantMachinery2024-03-3111234753ns5:PlantMachinery2023-03-3111234753ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3111234753ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3111234753ns10:OrdinaryShareClass12024-03-3111234753ns10:OrdinaryShareClass22024-03-31112347531ns10:Director12023-03-31112347531ns10:Director12022-03-31112347531ns10:Director12023-04-012024-03-31112347531ns10:Director12022-04-012023-03-31112347531ns10:Director12024-03-31112347531ns10:Director12023-03-31
REGISTERED NUMBER: 11234753 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

BROADLAND HEARING CARE LIMITED

BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 23,029 27,052

CURRENT ASSETS
Stocks 9,562 6,735
Debtors 5 23,446 18,997
Cash at bank 33,688 47,190
66,696 72,922
CREDITORS
Amounts falling due within one year 6 30,928 29,722
NET CURRENT ASSETS 35,768 43,200
TOTAL ASSETS LESS CURRENT
LIABILITIES

58,797

70,252

CREDITORS
Amounts falling due after more than one
year

7

(7,640

)

(7,640

)

PROVISIONS FOR LIABILITIES (2,101 ) (2,752 )
NET ASSETS 49,056 59,860

CAPITAL AND RESERVES
Called up share capital 8 2 2
Retained earnings 49,054 59,858
SHAREHOLDERS' FUNDS 49,056 59,860

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 November 2024 and were signed on its behalf by:




Mr B D Jones - Director



Mr S R Impey - Director


BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1. STATUTORY INFORMATION

Broadland Hearing Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11234753

Registered office: 135 High Street
Stalham
Norwich
Norfolk
NR12 9BB

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost, 25% on reducing balance and 4% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 56,905
Additions 790
At 31 March 2024 57,695
DEPRECIATION
At 1 April 2023 29,853
Charge for year 4,813
At 31 March 2024 34,666
NET BOOK VALUE
At 31 March 2024 23,029
At 31 March 2023 27,052

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 23,446 18,997

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 21,178 20,022
Other creditors 9,750 9,700
30,928 29,722

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Other creditors 7,640 7,640

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
2 2

BROADLAND HEARING CARE LIMITED (REGISTERED NUMBER: 11234753)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mr B D Jones and Mr S R Impey
Balance outstanding at start of year 14,320 (18,373 )
Amounts advanced 86,206 103,692
Amounts repaid (80,312 ) (70,999 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 20,214 14,320

The loan to the directors is interest free, unsecured and repayable on demand.